CVS Expands Formulary Exclusions In 2017, Express Scripts’ Tally Unchanged
National formulary exclusions continue in 2017, with CVS aggressively expanding its list of “not covered” drugs. Express Scripts currently excludes slightly fewer drugs than last year but may still add to its list.
You may also be interested in...
In Bristol/Pfizer's ARISTOPHANES real-world study, the rate of major bleeding with Eliquis was 46% lower than J&J/Bayer's Xarelto and 33% lower than Boehringer's Pradaxa.
And for diabetes, Jardiance is out and Invokana is in; CVS formulary update includes far fewer exclusions than previous years and reinstates coverage for several drugs, signaling more muted approach to management.
Pharmacy benefit manager adds 64 drugs to its list of formulary exclusions for 2018, bringing to 159 the number designated as not covered.